Allogene Therapeutics Inc Stock Performance
as on May 2, 2026 at 6:59 am IST
Day's Low
Day's High
$2.08$2.17
3.26%
Downside
0.93%
Upside
52 Week's Low
52 Week's High
$0.86$4.4659.90%
Downside
107.44%
Upside
Allogene Therapeutics Inc share price movements today
- Previous Close
- $2.13
- Open
- $2.08
- Volume
- 4.9M
- Day's Low - High
- $2.08 - $2.17
- 52 Week Low - High
- $0.86 - $4.46
Allogene Therapeutics Inc Historical Returns
- 1 Month Return
- -13.31 %
- 3 Month Return
- + 14.97 %
- 1 Year Return
- + 26.47 %
- 3 Year Return
- -59.81 %
- 5 Year Return
- -93.05 %
Allogene Therapeutics Inc Stock Fundamentals & Key Indicators
Check Allogene Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$739.6M
EPS (TTM)
-0.6696
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0PEG Ratio
0EBITDA
-194.6M
Revenue (TTM)
-
Profit Margin
0.00%
Return On Equity TTM
-53.42%
Allogene Therapeutics Inc vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Allogene Therapeutics Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $739.6M | -93.05% | NA | 0.00% | |
| BUY | $41.3B | 110.54% | 77.57 | 12.55% | |
| BUY | $108.7B | 94.28% | 27.93 | 32.94% | |
| NA | $32.7B | NA | 118.49 | 5.37% | |
| BUY | $74.1B | 45.73% | 17.27 | 29.65% |
Stock Returns calculator for Allogene Therapeutics Inc Stock including INR - Dollar returns
The Allogene Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Allogene Therapeutics Inc investment value today
Current value as on today
₹1,42,007
Returns
₹42,007
(+42.01%)
Returns from Allogene Therapeutics Inc Stock
₹26,471 (+26.47%)
Dollar Impact
₹15,536 (+15.54%)
Analyst Recommendation on Allogene Therapeutics Inc Stock
Based on 23 analysts
73.91%
Buy
26.09%
Hold
0.00%
Sell
Based on 23 analysts, 73.91% of analysts recommend a 'BUY' rating for Allogene Therapeutics Inc. Average target price of $8.65
Allogene Therapeutics Inc Share Price Target
Get share price movements and forecasts by analysts on Allogene Therapeutics Inc.
What analysts predicted
75.14%UPSIDE
Target Price
$8.65
Current Price
$2.15
Analyzed by
23 Analysts
Target
$8.65
Allogene Therapeutics Inc target price $8.65, a slight upside of 75.14% compared to current price of $2.15. According to 23 analysts rating.
Allogene Therapeutics Inc Stock’s Investor Sentiment and Interest
Investment in Allogene Therapeutics Inc Shares on INDmoney has grown by 770.00% over the past 30 days, indicating increased transactional activity.
Time period: to
Change:770.00% versus previous 30 day period
Search interest for Allogene Therapeutics Inc Stock has increased by 302% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:302% versus previous 30 day period
Allogene Therapeutics Inc Quarterly Profit & Loss
All numbers in Millions USD
Allogene Therapeutics Inc Annual Profit & Loss
All numbers in Millions USD
Allogene Therapeutics Inc Quarterly Cash Flow
All numbers in Millions USD
Allogene Therapeutics Inc Annual Cash Flow
All numbers in Millions USD
Allogene Therapeutics Inc News & Key Events
Today's Timeline - 13 April
Mon, 10:20 PM
-Allogene Therapeutics surged nearly 30% after positive phase 2 data showed improved cancer cell eradication in lymphoma patients.
Insights on Allogene Therapeutics Inc
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTBest in 1 Year
In the last 1 year, ALLO has outperformed top 5 stocks with highest market-cap in its industry
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 7 quarters, -66.35M → -38.81M (in $), with an average increase of 9.7% per quarter
NO EFFECTAgainst Peers
In the last 3 years, Allogene Therapeutics, Inc. has experienced a drawdown of -59.8%, however Alnylam Pharmaceuticals, Inc. resisted the overall trend and outperformed by 47.6%
NEGATIVE IMPACTPrice Dip
In the last 1 month, ALLO stock has moved down by -13.3%
- NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 22.0K → -22.0K (in $), with an average decrease of 200.0% per quarter
About Allogene Therapeutics Inc
| Organisation | Allogene Therapeutics Inc |
| Headquarters | 210 East Grand Avenue, South San Francisco, CA, United States, 94080 |
| Industry | Biotechnology |
| CEO | Dr. David D. Chang M.D., Ph.D. |
| E-voting on shares | Click here to vote |
Key Management of Allogene Therapeutics Inc
Name | Title |
|---|---|
Ms. Christine Cassiano | Executive VP, Chief Corporate Affairs & Brand Strategy Officer |
Ms. Annie Yoshiyama | SVP & Corporate Controller |
Dr. David D. Chang M.D., Ph.D. | Co-Founder, President, CEO & Director |
Dr. Zachary J. Roberts M.D., Ph.D. | Executive VP of Research & Development and Chief Medical Officer |
Mr. Geoffrey M. Parker | Executive VP & CFO |
Mr. Benjamin M. Beneski | Senior VP & Chief Technical Officer |
Dr. Arie S. Belldegrun F.A.C.S., M.D. | Co-Founder & Executive Chairman |
Mr. Joshua A. Kazam | Co-Founder & Director |
Mr. Earl M. Douglas Esq. | Senior VP, General Counsel, Compliance Officer & Corporate Secretary |
Ms. Susan R. Lundeen | Chief People Officer |
FAQs
What is Allogene Therapeutics Inc share price today?
Allogene Therapeutics Inc share price today is $2.15 as on at the close of the market. Allogene Therapeutics Inc share today touched a day high of $2.17 and a low of $2.08.
What is the 52 week high and 52 week low for Allogene Therapeutics Inc share?
Allogene Therapeutics Inc share touched a 52 week high of $4.46 on and a 52 week low of $0.86 on . Allogene Therapeutics Inc stock price today i.e. is closed at $2.15,which is 51.79% down from its 52 week high and 149.39% up from its 52 week low.
What is Allogene Therapeutics Inc's market capitalisation today?
Allogene Therapeutics Inc market capitalisation is $0.00T as on .
How to invest in Allogene Therapeutics Inc Stock (ALLO) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Allogene Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Allogene Therapeutics Inc Shares that will get you 0.6977 shares as per Allogene Therapeutics Inc share price of $2.15 per share as on May 2, 2026 at 1:29 am IST.
What is the minimum amount required to buy Allogene Therapeutics Inc Stock (ALLO) from India?
Indian investors can start investing in Allogene Therapeutics Inc (ALLO) shares with as little as ₹94.91 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.10 in Allogene Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Allogene Therapeutics Inc share’s latest price of $2.15 as on May 2, 2026 at 1:29 am IST, you will get 4.6512 shares of Allogene Therapeutics Inc. Learn more about
fractional shares .
What are the returns that Allogene Therapeutics Inc has given to Indian investors in the last 5 years?
Allogene Therapeutics Inc stock has given -93.05% share price returns and 28.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?